acute lymphoblastic leukaemia

Real-world data backs Kymriah’s safety profile, says Novartis

https://pharmaphorum.com/news/real-world-data-backs-kymriahs-safety-profile-says-novartis/

Gilead expands CAR-T deal with MaxCyte, Precision files for $100m IPO

https://pharmaphorum.com/news/gilead-expands-car-t-deal-with-maxcyte-precision-files-for-100m-ipo/

Amgen’s blood cancer drug gets full EU licence

https://pharmaphorum.com/news/amgens-blood-cancer-drug-blincyto-licence/

NICE to reassess Pfizer blood cancer drug

https://pharmaphorum.com/news/nice-reassess-pfizer-blood-cancer-drug/

Novartis close to first-ever CAR-T approval after unanimous vote

https://pharmaphorum.com/news/novartis-car-t-ctl019-backed-fda-advisers/

Pfizer facing NICE showdown over leukaemia drug

https://pharmaphorum.com/news/pfizer-facing-nice-showdown-drug/

NICE backs Amgen’s Blincyto in rare leukaemia

https://pharmaphorum.com/news/nice-backs-amgens-blincyto-rare-leukaemia/

Close in 10 seconds

Pharmaphorum.com

Search